We bring cannabis medicines into Europe, and build the brands that carry them.
Motagon distributes its own Mota® brand and third-party brands in Czechia and Poland, and provides EU-GMP testing and release for producers entering the European market.
Licences held
- EU-GMP Part I
Finished medicinal products · since July 2026 - EU-GMP Part II
Active substances · since 2022 - EU-GDP
Good Distribution Practice · since 2020 - Narcotics handling
Addictive substances and preparations · since 2020
Every licence is publicly verifiable on the European Medicines Agency’s EudraGMDP database.
What we do
Three things, done properly.
Motagon is a licensed pharmaceutical company. Everything we do runs through the same quality system and the same EU-GMP release point in Prague.
01
Mota® brand distribution
Our own EU-GMP medical cannabis range, built cultivar by cultivar and dispensed through pharmacies in the Czech Republic. Non-irradiated throughout.
02
Third-party brand distribution
We bring other producers’ brands to market, including Curaleaf, for which we are the exclusive distributor in the Czech Republic.
03
GMP services
QP release, QA release, EU-GMP testing, storage, labelling and secondary packing, and distribution into Germany, the United Kingdom and other European markets. Your route in, under our licences.
GMP services
From anywhere in the world. Released in Europe.
Producers who need a compliant route into the European market can use Motagon as their release point. We receive, test, label, secondary-pack and release under Qualified Person oversight, then distribute through GDP-certified wholesalers. EU-GMP processing (drying, trimming and repacking) is also part of the service.
01 · Source
- North America
- Europe
- Africa
- Australia / New Zealand
02 · Process & release
Czechia
Motagon s.r.o., Prague
EU-GMP Processing
Drying, trimming and repacking.
EU-GMP Part II: Active substance
Testing and release of cannabis as API.
EU-GMP Part I: Finished product
Labelling, packing and batch release of finished medicines.
Qualified Person release · GDP · Narcotics licence
03 · End markets
Germany
United Kingdom
European Union
Global sourcing
Sourced on quality, not on proximity.
We source from leading growers across North America, Europe, Africa, and Australia and New Zealand, selected on cannabinoid and terpene profile rather than on how close the grower is to Prague.
Every batch is released to EU-GMP in Czechia before it reaches a pharmacy, so a wider choice of cultivar never means a lower standard of control.
Markets
Czechia and Poland today. More as they open.
Motagon sells into Czechia and Poland, supplying pharmacies through GDP-certified wholesale partners, with a field force calling on prescribers and pharmacies in the Czech Republic.
For producers, Germany, the United Kingdom and other European markets are destinations we can release and ship into as a service, with the commercial relationship staying with the producer. How that works.
Where would you like to start?
Healthcare professionals
Product specifications, dispensing codes, certificates of analysis, the prescribing pathway and the evidence base.
Patients and carers
What medical cannabis is, how treatment works, and how to talk to your doctor about it.
Producers and partners
EU-GMP testing and release, brand development, and distribution into European markets.
Pharmacies
How to order, how to become a partner pharmacy, and how to receive availability updates for every batch we release.